Abstract
The aim of the present study was to characterize the effects of chronic nitric oxide synthase (NOS) inhibition on the alterations of regulatory myocardial proteins of intracellular signaling pathways (mitogen-activated protein kinase (MAPK) and Akt kinase cascades) and matrix metalloproteinases (MMP). Chronic NO deficiency (NOD) was induced by NG-nitro-L-arginine methyl ester (L-NAME, 40mg/kg/day, 4 weeks). Protein levels and activation of protein kinases were determined using specific antibodies, activities of MMP were analyzed by zymography in gels containing gelatin as a substrate. The development of NOD was associated with decreased activation of endothelial NOS (eNOS) and down-regulation of protein level of inducible NOS (iNOS). Investigation of kinase pathways revealed that the activation of extracellular signal-regulated kinases (ERK) and the levels of upstream activators of ERK (aFGF, H-Ras) were decreased after L-NAME treatment. Western blot analysis revealed that chronic application of L-NAME also decreased the activation of Akt kinase as compared with control hearts. Study of MMPs showed that in L-NAME-treated rat hearts activities of tissue MMP-2 were decreased. It is concluded that development of NOD resulted in inhibition of ERK and Akt kinase pathways and these changes suggest the involvement of these cascades in responses of myocardium to NOD. The results also point to the possible relationship between ERK and Akt kinase pathways and activation of eNOS and/or MMP-2.
Similar content being viewed by others
References
Ignarro LJ, Napoli C, Loscalzo J (2002) Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 90(1):21–28
Pernow J, Uriuda Y, Wang QD, Li XS, Nordlander R, Rydeén L (1994) The protective effect of L-arginine on myocardial injury and endothelial function following ischaemia and reperfusion in the pig. Eur Heart J 15(12):1712–1719
Andelova E, Bartekova M, Pancza D, Styk J, Ravingerova T (2005) The role of NO in ischemia/reperfusion injury in isolated rat heart. Gen Physiol Biophys 24(4):411–426
Horimoto H, Gaudette GR, Saltman AE, Krukenkamp IB (2000) The role of nitric oxide, K(+)(ATP) channels, and cGMP in the preconditioning response of the rabbit. J Surg Res 92(1):56–63
Hill M, Takano H, Tang XL, Kodani E, Shirk G, Bolli R (2001) Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation 104(6):694–699
Tao L, Gao E, Jiao X, Yuan Y, Li S, Christopher TA, Lopez BL, Koch W, Chan L, Goldstein BJ, Ma XL (2007) Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115(11):1408–1416
Li D, Qu Y, Tao L, Liu H, Hu A, Gao F, Sharifi-Azad S, Grunwald Z, Ma XL, Sun JZ (2006) Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury. J Surg Res 131(1):64–72
Pechanova O, Bernatova I, Pelouch V, Babal P (1999) L-NAME-induced protein remodeling and fibrosis in the rat heart. Physiol Res 48(5):353–362
Pechanova O, Bernatova I, Pelouch V, Simko F (1997) Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril. J Mol Cell Cardiol 29(12):3365–3374
Simko F, Pelouch V, Torok J, Luptak I, Matuskova J, Pechanova O, Babal P (2005) Protein remodeling of the heart ventricles in hereditary hypertriglyceridemic rat: effect of ACE-inhibition. J Biomed Sci 12(1):103–111
Barancik M, Simoncikova P, Bartekova M, Pechanova O, Ravingerová T (2005) The effect of chronic NOS inhibition on ischemic tolerance and regulatory proteins in rat hearts. J Mol Cell Cardiol 38(6):1072
Cao JL, Liu HL, Wang JK, Zeng YM (2006) Cross talk between nitric oxide and ERK1/2 signaling pathway in the spinal cord mediates naloxone-precipitated withdrawal in morphine-dependent rats. Neuropharmacology 51(2):315–326
Zhang XP, Hintze TH (2006) cAMP signal transduction induces eNOS activation by promoting PKB phosphorylation. Am J Physiol Heart Circ Physiol 290(6):H2376–H2384
Endo S, Launey T (2003) Nitric oxide activates extracellular signal-regulated kinase 1/2 and enhances declustering of ionotropic glutamate receptor subunit 2/3 in rat cerebellar Purkinje cells. Neurosci Lett 350(2):122–126
Peterson JT, Hallak H, Johnson L, Li H, O’Brien PM, Sliskovic DR, Bocan TM, Coker ML, Etoh T, Spinale FG (2001) Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 103(18):2303–2309
Cheung PY, Sawicki G, Wozniak M, Wang W, Radomski MW, Schulz R (2000) Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation 101(15):1833–1839
Wang W, Sawicki G, Schulz R (2002) Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res 53(1):165–174
Kurata H, Thant AA, Matsuo S, Senga T, Okazaki K, Hotta N, Hamaguchi M (2000) Constitutive activation of MAP kinase kinase (MEK1) is critical and sufficient for the activation of MMP-2. Exp Cell Res 254(1):180–188
Bae IH, Park MJ, Yoon SH, Kang SW, Lee SS, Choi KM, Um HD (2006) Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Cancer Res 66(10):4991–4995
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal Biochem 72:248–254
Schönbeck U, Mach F, Sukhova GK, Murphy C, Bonnefoy JY, Fabunmi RP, Libby P (1997) Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes. Circ Res 81:448–454
Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Inoue M, Tada M, Hori M, Kamada T (1996) Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction. Circulation 93(2):356–264
Hare JM, Loh E, Creager MA, Colucci WS (1995) Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 92(8):2198–2203
Saito T, Hu F, Tayara L, Fahas L, Shennib H, Giaid A (2002) Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure. Am J Physiol Heart Circ Physiol 283(1):H339–H345
Pechanova O, Dobesova Z, Cejka J, Kunes J, Zicha J (2004) Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase. J Hypertens 22(1):167–173
Mishra OP, Zubrow AB, Ashraf QM (2004) Nitric oxide-mediated activation of extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK) during hypoxia in cerebral cortical nuclei of newborn piglets. Neuroscience 123(1):179–186
Eitenmuller I, Volger O, Kluge A, Troidl K, Barancik M, Cai WJ, Heil M, Pipp F, Fischer S, Horrevoets AJ, Schmitz-Rixen T, Schaper W (2006) The range of adaptation by collateral vessels after femoral artery occlusion. Circ Res 99(6):656–662
Bernatova I, Pechanova O, Pelouch V, Simko F (2000) Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril. J Mol Cell Cardiol 32(2):177–185
Moreno H Jr, Piovesan Nathan L, Pereira Costa SK, Metze K, Antunes E, Zatz R, De Nucci G (1995) Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis. Eur J Pharmacol 287(1):93–96
Fernandez-Patron C, Stewart KG, Zhang Y, Koivunen E, Radomski MW, Davidge ST (2000) Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 87(8):670–676
Lalu MM, Csonka C, Giricz Z, Csont T, Schulz R, Ferdinandy P (2002) Preconditioning decreases ischemia/reperfusion-induced release and activation of matrix metalloproteinase-2. Biochem Biophys Res Commun 296(4):937–941
Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H (2001) Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 276(31):29596–29602
Acknowledgment
Supported by VEGA SR grants No. 2/6170/26, 2/5110/27, 2/6148/27, APVV 51-027404, SP51/028 09 00/028 09 01.
Author information
Authors and Affiliations
Corresponding author
Additional information
Anna Špániková and Petra Šimončíková have contributed equally to the study.
Rights and permissions
About this article
Cite this article
Špániková, A., Šimončíková, P., Ravingerová, T. et al. The effect of chronic nitric oxide synthases inhibition on regulatory proteins in rat hearts. Mol Cell Biochem 312, 113–120 (2008). https://doi.org/10.1007/s11010-008-9726-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-008-9726-4